Glimepiride Tablet 2 mg (Glimepiride)
Glimepiride 20mg
Tablet · Prescription medication
Highple Life Science Co., Ltd.
MFDS item code 201904328 · Approved 2019.06.24
This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication aids in controlling blood sugar in patients with type 2 diabetes along with dietary and exercise therapy. It can effectively control blood sugar when used alone. If blood sugar control is inadequate with oral hypoglycemic agents alone, it may be used in combination with insulin. Additionally, when control is difficult with sulfonylureas or metformin monotherapy, this medication may be used with metformin to improve blood sugar control. This medication helps to manage blood sugar levels reliably in patients with type 2 diabetes.
The dose should be adjusted individually for each patient. Swallow without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As treatment progresses, improved diabetes control may reduce the amount of this medicine needed. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Additionally, individuals who have had allergic reactions to this medication or sulfonylureas or sulfonamides should not be administered this medication. In patients with severely impaired liver or kidney function, it is recommended to switch to insulin therapy instead of using this medication. Women who are pregnant or may become pregnant and breastfeeding women should not take this medication. Patients with severe infections, before or after surgery, or those with severe trauma may require insulin therapy, making this medication unsuitable. Conditions like diarrhea or vomiting can affect food absorption, increasing the risk of hypoglycemia. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should avoid taking it. During the initial week of dosing, there is a heightened risk of hypoglycemia, requiring careful monitoring. Particularly, older adults, individuals with poor nutritional status or those who skip meals, those with an imbalance between exercise and food intake, and individuals who consume alcohol frequently are at increased risk of hypoglycemia. Patients with impaired kidney or liver function, as well as those who overdose on this medication, should also be cautious regarding hypoglycemia. Endocrine disorders such as thyroid abnormalities or adrenal insufficiency should also be considered for careful administration. When taking this medication with other drugs, interactions may alter the risk of hypoglycemia, so consultation with a doctor or pharmacist is necessary. Individuals allergic to Yellow No. 4 (Tartrazine) present in this medication should also exercise caution. Symptoms of hypoglycemia may occur while taking this medication, including headache, severe hunger, nausea, fatigue, anxiety, confusion, visual disturbances, dizziness, drowsiness, and reduced consciousness. Hypoglycemia can be rapidly controlled by sugar intake, so it is important to always carry sugar. Temporary blurred vision, gastrointestinal disturbances, liver dysfunction, blood abnormalities, and allergic reactions may occur rarely; symptoms should be promptly reported to healthcare personnel. While taking this medication, regular meals, exercise, and weight management should be practiced, and blood sugar control should be continuously monitored. Teaching patients and their families about the risks and symptoms of hypoglycemia, as well as treatment methods, is essential. Especially in situations of severe stress, surgery, or infection, blood sugar control may become challenging, necessitating a switch to insulin therapy. This medication should not be used during pregnancy or lactation due to potential harm to the fetus and newborn; insulin therapy should be switched if necessary. It is not used in children under 18 years of age as safety and efficacy have not been established. Elderly patients may require dose adjustments due to decreased kidney function. In cases of overdose, severe hypoglycemia may occur, necessitating immediate treatment at a medical institution, with emergency measures such as inducing vomiting, blocking drug absorption, or administering glucose injections if necessary.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and damp skin, tachycardia, hypertension, palpitations, angina, deep vein thrombus, blurred vision, feelings of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, skin and mucous membrane syndrome, allergic vasculitis, photosensitive reactions in the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature in the range of 1 degree to 30 degrees Celsius. Storing it this way preserves the effectiveness of the medication.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 20mg
Tablet · Prescription medication
Highple Life Science Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.